Article
Fremont, CA-Nine months into its hyperopia clinical study, Nidek has analyzed 248 of the 300 eyes to be studied for the treatment of hyperopia and hyperopic astigmatism.
Floppy iris syndrome risk: Study finds women more susceptible, key drugs identified
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Iantrek announces positive 2-year results from clinical study of its bio-interventional platform for uveoscleral outflow enhancement
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200
Formosa Pharmaceuticals enters into licensing agreement with Cipla for commercialization of APP13007 across 11 countries